{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03396341",
            "nctIdAliases": [
                "NCT04943250"
            ],
            "orgStudyIdInfo": {
                "id": "17-489"
            },
            "organization": {
                "fullName": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations",
            "officialTitle": "Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations",
            "therapeuticArea": [
                "Rare Diseases",
                "Other"
            ],
            "study": "responses-to-genetic-risk-modifier-testing-among-women-with-mutations"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-01-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-01-05",
            "studyFirstSubmitQcDate": "2018-01-05",
            "studyFirstPostDateStruct": {
                "date": "2018-01-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Phenogen Sciences",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare."
        },
        "conditionsModule": {
            "conditions": [
                "Genetic Testing",
                "BRCA1/2"
            ],
            "keywords": [
                "BRCA1/2 Mutations",
                "17-489"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "saliva sample"
            },
            "enrollmentInfo": {
                "count": 350,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "patients receiving a positive BRCA1/2 mutation result",
                    "description": "All interested participants will provide a saliva sample for genetic risk modifier testing, and will complete Assessment #1 questionnaires. Participants will be contacted 1 week later (+/- 1 week) to complete Assessment #2 questionnaires. Participants will be contacted 6 months (+/- 3 weeks) following the receipt of their genetic risk modifier results to complete Assessment #3 questionnaires. Participants will be encouraged to complete Assessments #2 and #3 via email using the secure, approved REDCap system",
                    "interventionNames": [
                        "Other: Salvia sample",
                        "Behavioral: Questionnaires"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Salvia sample",
                    "description": "salvia sample",
                    "armGroupLabels": [
                        "patients receiving a positive BRCA1/2 mutation result"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Questionnaires",
                    "description": "Participants will complete Assessment #1 questionnaires. Participants will be contacted 1 week later (+/- 1 week) to complete Assessment #2 questionnaires. Participants will be contacted 6 months (+/- 3 weeks) following the receipt of their genetic risk modifier results to complete Assessment #3 questionnaires. Participants will be encouraged to complete Assessments #2 and #3 via email using the secure, approved REDCap system",
                    "armGroupLabels": [
                        "patients receiving a positive BRCA1/2 mutation result"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "number of patients that opt for preventive mastectomy or to pursue surveillance",
                    "description": "Hierarchical level modeling (HLM) will be implemented to assess the effect of genetic risk modifier testing on Decisional Conflict Scale score (DCS), allowing for baseline effects via a random intercept.",
                    "timeFrame": "3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patient, age 25 years or older (given that women under this age are not generally recommended to receive BRCA1/2 genetic testing)\n* Completed full sequence or targeted genetic testing with a clinically confirmed BRCA1 or BRCA2 deleterious mutation identified\n* No personal history of breast cancer\n* English-fluent; the surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.\n\nExclusion Criteria:\n\n* Previous receipt of any prophylactic mastectomy.\n* Major psychiatric illness or cognitive impairment that in the judgment of the study investigators or study staff would preclude study participation.\n* Any patients who are unable to comply with the study procedures as determined by the study investigators or study staff.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "BRACA 1/2 mutation carriers",
            "minimumAge": "25 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Potential participants (i.e., patients receiving a positive BRCA1/2 mutation result) will be identified and approached by their primary genetic counselor.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jada Hamilton, PhD, MPH",
                    "role": "CONTACT",
                    "phone": "646-888-0049",
                    "email": "hamiltoj@mskcc.org"
                },
                {
                    "name": "Mark Robson, MD",
                    "role": "CONTACT",
                    "phone": "646-888-5486"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jada Hamilton, PhD, MPH",
                    "affiliation": "Memorial Sloan Kettering Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Dana Farber Cancer Institute (Data Collection Only)",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Judy Garber, MD, MPH",
                            "role": "CONTACT",
                            "phone": "617-632-5961"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Memorial Sloan-Kettering at Basking Ridge",
                    "status": "RECRUITING",
                    "city": "Basking Ridge",
                    "state": "New Jersey",
                    "zip": "07920",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jada Hamilton, PhD, MPH",
                            "role": "CONTACT",
                            "phone": "646-888-0049"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.70621,
                        "lon": -74.54932
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Commack",
                    "status": "RECRUITING",
                    "city": "Commack",
                    "state": "New York",
                    "zip": "11725",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jada Hamilton, PhD, MPH",
                            "role": "CONTACT",
                            "phone": "646-888-0049"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84288,
                        "lon": -73.29289
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Westchester",
                    "status": "RECRUITING",
                    "city": "Harrison",
                    "state": "New York",
                    "zip": "10604",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jada Hamilton, PhD, MPH",
                            "role": "CONTACT",
                            "phone": "646-888-0049"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.96899,
                        "lon": -73.71263
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jada Hamilton, PhD, MPH",
                            "role": "CONTACT",
                            "phone": "646-888-0049"
                        },
                        {
                            "name": "Mark Robson, MD",
                            "role": "CONTACT",
                            "phone": "646-888-5486"
                        },
                        {
                            "name": "Jada Hamilton, PhD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Nassau",
                    "status": "RECRUITING",
                    "city": "Uniondale",
                    "state": "New York",
                    "zip": "11553",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jade Hamilton, PhD, MPH",
                            "role": "CONTACT",
                            "phone": "646-888-0049"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.70038,
                        "lon": -73.59291
                    }
                },
                {
                    "facility": "Abramson Cancer Center at University of Pennsylvania Medical Center (Data Collection Only)",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104-4283",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Susan Domchek, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Memorial Sloan Kettering Cancer Center",
                    "url": "http://www.mskcc.org/mskcc/html/44.cfm"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}